ATE238315T1 - Verfahren zur herstellung von dinatriumpamidronat - Google Patents

Verfahren zur herstellung von dinatriumpamidronat

Info

Publication number
ATE238315T1
ATE238315T1 AT99964198T AT99964198T ATE238315T1 AT E238315 T1 ATE238315 T1 AT E238315T1 AT 99964198 T AT99964198 T AT 99964198T AT 99964198 T AT99964198 T AT 99964198T AT E238315 T1 ATE238315 T1 AT E238315T1
Authority
AT
Austria
Prior art keywords
disodium pamidronate
producing disodium
producing
pamidronate
provides
Prior art date
Application number
AT99964198T
Other languages
English (en)
Inventor
Edward C Shinal
Original Assignee
Aesgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27395334&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE238315(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/209,153 external-priority patent/US6160165A/en
Priority claimed from US09/456,460 external-priority patent/US6794536B1/en
Application filed by Aesgen Inc filed Critical Aesgen Inc
Application granted granted Critical
Publication of ATE238315T1 publication Critical patent/ATE238315T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3873Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99964198T 1998-12-10 1999-12-10 Verfahren zur herstellung von dinatriumpamidronat ATE238315T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/209,153 US6160165A (en) 1998-12-10 1998-12-10 Method for preparation of disodium pamidronate
US41440199A 1999-10-07 1999-10-07
US09/456,460 US6794536B1 (en) 1998-12-10 1999-12-08 Method for preparation of disodium pamidronate
PCT/US1999/029284 WO2000034293A1 (en) 1998-12-10 1999-12-10 Method for preparation of disodium pamidronate

Publications (1)

Publication Number Publication Date
ATE238315T1 true ATE238315T1 (de) 2003-05-15

Family

ID=27395334

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99964198T ATE238315T1 (de) 1998-12-10 1999-12-10 Verfahren zur herstellung von dinatriumpamidronat

Country Status (6)

Country Link
EP (1) EP1135397B1 (de)
AT (1) ATE238315T1 (de)
AU (1) AU764157B2 (de)
CA (1) CA2353942A1 (de)
DE (1) DE69907258T2 (de)
WO (1) WO2000034293A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL125336A0 (en) 1998-07-14 1999-03-12 Yissum Res Dev Co Compositions for inhibition and treatment of restinosis
US6984400B2 (en) 1998-07-14 2006-01-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of treating restenosis using bisphosphonate nanoparticles
US7008645B2 (en) 1998-07-14 2006-03-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of inhibiting restenosis using bisphosphonates
AU2001293473A1 (en) * 2000-09-18 2002-03-26 Mayne Pharma International Pty Ltd Diphosphonate solutions
ITMI20010364A1 (it) * 2001-02-23 2002-08-23 Bioindustria Lab Italiano M Ed Procedimento per la preparazione del pamidronato disodico
EP1390044A4 (de) * 2001-05-02 2005-03-23 Sicor Inc Pamidronat-dinatrium zur injektion
CA2372450A1 (en) * 2001-05-10 2001-09-19 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
GB2383042A (en) 2001-10-18 2003-06-18 Cipla Ltd Amorphous alendronate sodium
ITMI20012634A1 (it) * 2001-12-13 2003-06-13 Istituto Biochimico Pavese Pha Metodo di preparazione del panidronato disodico anidro
ITMI20012751A1 (it) * 2001-12-21 2003-06-21 Lyogen Ltd Sale monosodico dell'acido pamidronico e procedimento per la sua preparazione
ITMI20020146A1 (it) * 2002-01-29 2003-07-29 Lyogen Ltd Alendronato monosodico amorfo e processo per la sua preparazione
US10517883B2 (en) 2003-06-27 2019-12-31 Zuli Holdings Ltd. Method of treating acute myocardial infarction
EP1689759B1 (de) * 2003-12-04 2016-07-13 Mustafa Nevzat Ilac Sanayii A.S. Verfahren zur herstellung von reinem dinatrium pamidronat
US9993427B2 (en) 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
US4639338A (en) * 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
EP0600834A1 (de) * 1992-11-30 1994-06-08 Ciba-Geigy Ag Verwendung von Methanbiphosphonsäurederivaten zur Herstellung eines Arzneimittels zur Behandlung von Knochenbrüchen
CN1144806A (zh) * 1996-07-25 1997-03-12 南京药物研究所 氨基二膦酸类骨吸收抑制剂及其钠盐的制备方法
DE19820974C2 (de) * 1998-05-12 2000-05-04 Henkel Kgaa Isolierung der Salze von 1-Hydroxy-1,1-diphosphonsäureverbindungen

Also Published As

Publication number Publication date
DE69907258D1 (de) 2003-05-28
WO2000034293A1 (en) 2000-06-15
DE69907258T2 (de) 2003-11-06
AU764157B2 (en) 2003-08-14
EP1135397A1 (de) 2001-09-26
EP1135397B1 (de) 2003-04-23
CA2353942A1 (en) 2000-06-15
AU2048900A (en) 2000-06-26

Similar Documents

Publication Publication Date Title
DE69909957D1 (de) Verfahren zur Herstellung von Schuhwerk
ATE238315T1 (de) Verfahren zur herstellung von dinatriumpamidronat
DE59800221D1 (de) Verfahren zur Stabilisierung von Retinol bzw. Retinol-Derivaten
ATE291567T1 (de) Verfahren zur herstellung von nitroxymethylphenylestern von aspirinderivaten
DE60222612D1 (de) Verfahren zur Herstellung von wasserfreiem Alkalisulfid
ATE327219T1 (de) Verfahren zur herstellung von hydroxymethylthiobuttersäure
ATE344273T1 (de) Verfahren zur herstellung von 21-hydroxy-6,19- oxidoprogesteron (21oh-6op)
DE69934948D1 (de) Verfahren zur cooxidation von organischen verbindungen
DE69935509D1 (de) Verfahren zur herstellung von durchscheinenden zahnersätzen
DE50200809D1 (de) Verfahren zur herstellung von n-phosphonomethyliminodiessigsäure
DE59806098D1 (de) Verfahren zur Herstellung von Phosphoniumsalzen
ATE281434T1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
DE69927943D1 (de) Verfahren zur herstellung von cefpodoxim-proxetil diastereoisomeren
ATE263175T1 (de) Verfahren zur herstellung von n-phosphonomethyl iminodiessigsäure
ATE238316T1 (de) Verfahren zur herstellung von phosphonomethylglycin
DE59804673D1 (de) Verfahren zur herstellung von vinylphosphonsäure-verbindungen
DE69701527D1 (de) Verfahren zur herstellung einer industriellen, wässrigen natrium-chloridlösung
DE69832063D1 (de) Ein verbessertes Verfahren zur Herstellung von stabilen wässrigen Urethandispersionen
ATE240337T1 (de) Verfahren zur herstellung von n- phosphonomethylglycin
DE69814420T2 (de) Stereoselektive verfahren zur herstellung von gabapentinanalogen
DE59902581D1 (de) Verfahren zur herstellung von vinylphosphonsäure-verbindungen
ATE256104T1 (de) Verfahren zur herstellung von indan-ähnlichen verbindungen
ATE268753T1 (de) Verfahren zur herstellung von 24(s)- hydroxyvitamin d2
DE69707639T2 (de) Verfahren zur herstellung einer aktivierten aminosäure
DE59800237D1 (de) Verfahren zur Herstellung von wasserfreiem 2-Amino-1-methoxypropan

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1135397

Country of ref document: EP